AR225143A1 - Procedimiento para preparar derivados de fenil-metil-hidantoina - Google Patents

Procedimiento para preparar derivados de fenil-metil-hidantoina

Info

Publication number
AR225143A1
AR225143A1 AR276599A AR27659979A AR225143A1 AR 225143 A1 AR225143 A1 AR 225143A1 AR 276599 A AR276599 A AR 276599A AR 27659979 A AR27659979 A AR 27659979A AR 225143 A1 AR225143 A1 AR 225143A1
Authority
AR
Argentina
Prior art keywords
fenyl
methyl
preparing
procedure
hydantoine
Prior art date
Application number
AR276599A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of AR225143A1 publication Critical patent/AR225143A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR276599A 1978-05-23 1979-05-21 Procedimiento para preparar derivados de fenil-metil-hidantoina AR225143A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (1)

Publication Number Publication Date
AR225143A1 true AR225143A1 (es) 1982-02-26

Family

ID=10161451

Family Applications (2)

Application Number Title Priority Date Filing Date
AR276599A AR225143A1 (es) 1978-05-23 1979-05-21 Procedimiento para preparar derivados de fenil-metil-hidantoina
AR284450A AR224186A1 (es) 1978-05-23 1981-02-26 Procedimiento para preparar una hidantoina

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR284450A AR224186A1 (es) 1978-05-23 1981-02-26 Procedimiento para preparar una hidantoina

Country Status (31)

Country Link
US (2) US4241073A (de)
EP (1) EP0005647B1 (de)
JP (1) JPS54160373A (de)
KR (1) KR830000635B1 (de)
AR (2) AR225143A1 (de)
AT (1) AT366034B (de)
AU (1) AU530968B2 (de)
BE (1) BE876435A (de)
BG (2) BG31799A3 (de)
CA (1) CA1120481A (de)
CH (2) CH639650A5 (de)
CS (2) CS208654B2 (de)
DD (1) DD143769A5 (de)
DE (1) DE2963061D1 (de)
DK (1) DK207579A (de)
ES (1) ES480850A1 (de)
FI (1) FI791614A (de)
FR (1) FR2426681A1 (de)
GB (1) GB1601310A (de)
GR (1) GR68363B (de)
HU (1) HU184648B (de)
IL (1) IL57343A (de)
LU (1) LU81300A1 (de)
MX (1) MX5604E (de)
NZ (1) NZ190512A (de)
PL (2) PL119612B1 (de)
PT (1) PT69648A (de)
RO (2) RO76807A (de)
SU (2) SU873878A3 (de)
YU (1) YU120179A (de)
ZA (1) ZA792501B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
HU204047B (en) * 1987-01-31 1991-11-28 Sandoz Ag Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
PT97507B (pt) * 1990-04-27 1998-08-31 Orion Yhtymae Oy Processo para apreparacao de novos derivados de catecol farmacologicamente activos
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
NZ532909A (en) * 2001-11-30 2006-08-31 Lilly Co Eli Peroxisome proliferator activated receptor agonists
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
EP2155692B1 (de) * 2007-05-30 2015-06-17 F. Hoffmann-La Roche AG Nicht-nukleosidische reverse-transkriptase-hemmer
CN101990534A (zh) * 2007-11-01 2011-03-23 Uab研究基金会 治疗和预防病毒感染
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
US3365296A (en) * 1964-05-18 1968-01-23 Gen Aniline & Film Corp Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (de) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
LU81300A1 (fr) 1980-12-16
BG32115A4 (en) 1982-05-14
AT366034B (de) 1982-03-10
FR2426681A1 (fr) 1979-12-21
YU120179A (en) 1983-02-28
SU988190A3 (ru) 1983-01-07
PL119612B1 (en) 1982-01-30
RO76807A (ro) 1981-04-26
PL222701A1 (de) 1980-12-15
AU4728979A (en) 1979-11-29
FI791614A (fi) 1979-11-24
US4241073A (en) 1980-12-23
AU530968B2 (en) 1983-08-04
JPS54160373A (en) 1979-12-19
CS208654B2 (en) 1981-09-15
BG31799A3 (en) 1982-03-15
PL125075B1 (en) 1983-03-31
GB1601310A (en) 1981-10-28
CH643546A5 (fr) 1984-06-15
PL215773A1 (de) 1980-07-14
AR224186A1 (es) 1981-10-30
KR830000635B1 (ko) 1983-03-23
DK207579A (da) 1979-11-24
PT69648A (en) 1979-06-01
IL57343A (en) 1982-09-30
RO79703A (ro) 1982-08-17
NZ190512A (en) 1984-10-19
CA1120481A (en) 1982-03-23
HU184648B (en) 1984-09-28
MX5604E (es) 1983-11-07
EP0005647B1 (de) 1982-06-09
US4293563A (en) 1981-10-06
FR2426681B1 (de) 1983-08-12
ATA373379A (de) 1981-07-15
DE2963061D1 (en) 1982-07-29
EP0005647A1 (de) 1979-11-28
GR68363B (de) 1981-12-23
ES480850A1 (es) 1980-02-01
CH639650A5 (fr) 1983-11-30
IL57343A0 (en) 1979-09-30
BE876435A (fr) 1979-11-21
SU873878A3 (ru) 1981-10-15
ZA792501B (en) 1980-05-28

Similar Documents

Publication Publication Date Title
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES494352A0 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
AR225143A1 (es) Procedimiento para preparar derivados de fenil-metil-hidantoina
MX5973E (es) Procedimiento para preparar compuestos cefem
ES490504A0 (es) Procedimiento para preparar nuevos compuestos de tiadiazoli-lo
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX5399E (es) Procedimiento para preparar derivados de propanona
ES492032A0 (es) Procedimiento para preparar compuestos de cefem
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
MX5724E (es) Procedimiento para preparar metil eteres de cetoximas sustituidas
ES493569A0 (es) Procedimiento de preparar derivados isoquinolinicos
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
AR228020A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina
AR223177A1 (es) Procedimiento para preparar derivados de indolo-isoquinolina
ES495971A0 (es) Procedimiento para obtener derivados de tiazol
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
MX150040A (es) Procedimiento mejorado para preparar 3-metil-ciclopentadecanona